Share of global clinical trials for rare diseases from 2010 to 2016, by disease type
This statistic shows the distribution of clinical trials worldwide for rare diseases from 2010 to 2016, by disease type. According to the data, 37 percent of clinical trials for rare diseases were focused on rare neoplastic diseases. Neoplastic diseases are diseases of unusual growth, mainly cancers, but could also include benign growths as well.